Raghunandhakumar Subramanian

Raghunandhakumar Subramanian

Auto-generated profile, based on publicly available information

Raghunandhakumar Subramanian

Cancer and Stem Cell Research Lab, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2019 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
MSMayank Sharma
Mayank Sharma
JPJuhee Pandya
Juhee Pandya
DPDivyangkumar M. Patel
Divyangkumar M. Patel
RVRuturajsinh M. Vala
Ruturajsinh M. Vala
VRV. Ramkumar
V. Ramkumar
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
A one-pot procedure for the preparation of functionalized 1,4-dihydropyridines by three-component reaction using substituted heterocyclic aldehydes, ammonium acetate, and substituted β-ketoesters catalyzed by L-proline was described. Present protocol offers excellent yield up to 92%, flexibility with different substitution, convenient operation, and eco-friendliness. The synthesized products were confirmed by 1H-NMR, 13C-APT, and IR spectroscopy. Herein, final confirmation of the targeted motif was made by X-ray single-crystal analysis of representative compounds (4f, 4j, 4k, 4l, and 4o). The chemically synthesized compounds were evaluated for the antiproliferative activity by cell viability (MTT) assay and dual AO/EB (acridine orange/ethidium bromide)-staining method against human A549 lung cancer cell lines. The viability of the treated cell was evaluated adopting MTT assay. According to associated changes in cell membranes during the process of apoptosis, a clear difference was observed between normal cells, early and late apoptotic cells, and necrotic cells. All compounds were found effective against Saccharomyces cerevisiae which was confirmed by increased reactive oxygen species production and DNA damage as compared to untreated yeast cell culture. Altogether, these compounds showed promising hope for application in pharmaceutical aid against yeast infections.

2 August 2021 in Nutrition and Cancer
Verified
Journal Article
Closed access
PEPerumal Elumalai
Perumal Elumalai
EDEzhilarasan Devaraj
Ezhilarasan Devaraj
SRSubramanian Raghunandhakumar
Subramanian Raghunandhakumar
Lung cancer is a first leading cause of cancer related death worldwide. Quercetin (QUE) has chemo-preventive effect against a variety of cancers. However, the molecular mechanism of QUE mediated inhibition of cancer cell migration and epithelial to mesenchymal transition (EMT) is not clear in lung cancer. Therefore, this study investigates the effect of QUE on EMT and metastasis of lung cancer cell line (A549). The MTT assay, scratch wound healing assay, Transwell migration and invasion assay performed to assess the cell viability and migration potential of lung cancer cells after treatment with different concentration of QUE. Further, chemokines gene expression was analyzed by qPCR and EMT markers were analyzed by immunocytochemistry and Western blot. QUE inhibits cell viability in a dose-dependent (10–80 μM) manner both at 24 and 48 h treatment. The Akt/MAPK/β-catenin and EMT marker protein expressions were decreased significantly, whereas TIMP-2 expression was increased upon QUE treatment. QUE inhibits cell migration and invasion of A-549 cells. In addition, Immunocytochemistry result showed that QUE can reduce nuclear translocalisation of β-catenin in A549 cells. Our results suggest that QUE can inhibit the metastatic potential in lung cancer by altering the Akt/MAPK/β-catenin signaling pathway and inhibiting the nuclear translocation of β-catenin.

20 August 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
PKPavani Koka
Pavani Koka
RMReddy Sailaja Mundre
Reddy Sailaja Mundre
RRRohini Rangarajan
Rohini Rangarajan
YCYamini Chandramohan
Yamini Chandramohan
RSRaghunandha Kumar Subramanian
Raghunandha Kumar Subramanian
ADAnuradha Dhanasekaran
Anuradha Dhanasekaran

5 May 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
JVJeyamanikandan Venkatachalam
Jeyamanikandan Venkatachalam
VJVeronica Shalini Jeyadoss
Veronica Shalini Jeyadoss
KBKabilan Subash Chandra Bose
Kabilan Subash Chandra Bose
RSRaghunandhakumar Subramanian
Raghunandhakumar Subramanian

10 April 2024 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Closed access
RMRamadurai Murugan
Ramadurai Murugan
STSilambarasan T
Silambarasan T
RSRaghunandhakumar Subramanian
Raghunandhakumar Subramanian
CSChitra S
Chitra S
SASaheb Ali
Saheb Ali

30 November 2020 in Bioinformation
Verified
Journal Article
Open access
KRK Ramamoorthy
K Ramamoorthy
SRSubramanian Raghunandhakumar
Subramanian Raghunandhakumar
RARs Anand
Rs Anand
APA Paramasivam
A Paramasivam
SKS Kamaraj
S Kamaraj
AVAshokkumar Veeramuthu
Ashokkumar Veeramuthu
Astaxanthin (AXN) is known to have health benefits by epidemiological studies. Therefore, it is of interest to assess the effect of AXN (derived from indigenous unicellular green alga Haematococcus lacustris) to modulate cell cycle arrest, lysosomal acidification and eventually apoptosis using in vitro in A549 lung cancer cells. Natural extracts of astaxanthin were obtained by standardized methods as reported earlier and characterized by standard HPLC and MS. Treatment of A549 cells with AXN (purified fraction) showed significant reduction in cell viability (about 50%) as compared to crude extract at 50µM concentration. Thus, we show the anticancer effects and lysosomal acidification in A549 cells by Astaxanthin from Haematococcus lacustris for further consideration. Together, our results demonstrated the anticancer potential of AXN from Haematococcus lacustris, which is found to be mediated via its ability to induce cell cycle arrest, lysosomal acidification and apoptotic induction.